Latest Blog Posts Tagged "Funding Priority Area"
December 10, 2018
An interim analysis concluded that the SURE-PD3 trial is unlikely to determine that inosine can slow Parkinson's progression. The trial therefore is ending earlier than planned.
August 10, 2018
An MJFF-funded study suggests that a drug targeting the LRRK2 genetic mutation may positively impact the broader PD population.
July 26, 2018
Four leading brain research organizations are funding projects to look across diseases such as Parkinson's and Alzheimer's for commonalities and differences.
June 27, 2018
In the first video in our new series, MJFF's Dr. Mark Frasier discusses innovative Parkinson's research projects chosen through our biannual funding round.
April 19, 2018
Foundation-funded research lays groundwork to deepen understanding of Parkinson's and speed breakthroughs.
March 14, 2018
A study funded by the Foundation suggests a form of non-invasive brain stimulation may help relieve these PD symptoms.
March 09, 2018
More than 40 experts convened at the MJFF offices to discuss how to advance therapies against Parkinson's genetic target GBA.
January 12, 2018
Michael J. Fox Foundation-funded researchers have created exquisitely sensitive antibodies that may help test therapies against a top Parkinson's drug target.
June 13, 2014
A new study shows two avenues through which inhibiting the function of the protein LRRK2 may help treat people with Parkinson's, even those without a LRRK2 genetic mutation.
June 05, 2014
Our monthly roundup of projects that we've recently funded includes ones that span our research portfolio. These grants support work on motor symptoms, cognition and genetics.